U.S. Dental Anesthesia Market Revenue & Forecast Analysis, 2026-2035
The U.S. dental anesthesia market was valued at USD 667.05 million in 2025. The market is expected to grow at a CAGR of 6.9% from USD 704.54 million in 2026 to USD 1,280.96 million in 2035. The market is propelled by surging dental procedure rates, heightened patient demand for painless dentistry, increased use of sedation methods, and ongoing improvements in anesthetic formulations and administration systems. High dental-care expenditure and the country's established dental-care framework also bolster the market.
Market Overview
The American Dental Association (ADA) states that dental treatments needing efficient pain control are widely conducted throughout the United States, maintaining a consistent need for local anesthetics and associated delivery methods. The expanding number of restorative and surgical dental treatments, rising patient demand for pain-free care, and innovations in local anesthetic formulations and delivery methods are fueling the expansion of the U.S. dental anesthesia market.
The U.S. dental anesthesia market has witnessed steady historical growth, supported by increasing dental procedure volumes, greater emphasis on pain management, and the widespread use of local anesthetics across dental clinics and hospitals. For instance, in 2024, Septodont strengthened its U.S. presence through a strategic investment in Balanced Pharma, Inc., supporting the development of next-generation dental anesthetics and expanding innovation in pain-management solutions.
The market is expected to maintain consistent growth over the forecast period, driven by rising demand for pain-free dental procedures, expanding restorative and surgical dentistry, and advancements in anesthesia delivery technologies. For instance, in 2025, Dentsply Sirona continued to strengthen its dental anesthesia portfolio as one of the leading players in the dental anesthetics market, while Milestone Scientific continued advancing computer-controlled anesthesia delivery technologies.
U.S. Dental Anesthesia Market Overview
Base Year Market Size (2025): USD 667.05 Million
CAGR: 6.9%
Forecast Year Market Size (2035): USD 1,280.56 Million
Major Players:
Dentsply Sirona Inc.
Septodont Inc.
Milestone Scientific, Inc.
3M Company
Centrix, Inc.
U.S. Dental Anesthesia Market Trends
The U.S. dental anesthesia market is evolving toward more precise, patient-focused, and technology-enabled pain-management solutions. Growth is being shaped by rising demand for comfortable dental procedures, advancements in anesthesia delivery, and stronger emphasis on safety and standardized sedation practices.
· Dental practices are increasingly focusing on reducing injection discomfort, anxiety, residual numbness, and overall treatment-related stress, supporting demand for targeted and comfortable anesthesia options.
· Greater acceptance of sedation for patients with dental anxiety, complex procedures, and special-care requirements is supporting the broader use of sedation and general anesthesia in dental settings.
· Manufacturers are developing formulations and delivery approaches aimed at faster onset, predictable duration, improved comfort, and more targeted pain control. Local anesthesia continues to represent the largest anesthesia-type segment in the U.S. market.
· AI-assisted dosing, automated monitoring, and digitally controlled delivery are emerging as areas of innovation, particularly for improving precision and safety in medically complex patients.
· Newer systems are increasingly designed to anesthetize the treatment area more selectively, potentially reducing unnecessary facial numbness and improving the patient experience. For instance, in 2025, Dentalhitec launched its QuickSleeper5 system in the U.S. following FDA clearance.
Collectively, the U.S. dental anesthesia market is moving from conventional syringe-based approaches toward more precise delivery, targeted numbness, improved patient comfort, digital control, and stronger safety protocols.
U.S. Dental Anesthesia Market Analysis
By Product Type
Local anesthesia dominates the U.S. dental anesthesia market, supported by its routine use across restorative, endodontic, periodontal, extraction, and minor surgical procedures.
Based on product, the U.S. dental anesthesia market is categorized into local, sedation, and general anesthesia. The local anesthesia segment holds the largest market share of 74.50% in 2025.
By Application
Restorative Dentistry dominates the U.S. dental anesthesia market due to the high volume of routine procedures such as fillings, crown preparation, bridges, and other restorative treatments that frequently require local anesthesia
Based on application, the U.S. dental anesthesia market is categorized into restorative dentistry, endodontics, surgical, periodontics, and orthodontic applications. Restorative dentistry holds the largest market share in 2025.
By End-use
Dental Clinics dominate the U.S. dental anesthesia market due to their high volume of routine and specialized dental procedures, including restorative, endodontic, periodontal, and minor surgical treatments.
Based on end-use, the U.S. dental anesthesia market is categorized into dental clinics, hospitals, ambulatory surgery centers (ASCs), and academic & research institutes. Dental clinics hold the largest market share in 2025.
Key Companies Profiled
The U.S. dental anesthesia market is moderately consolidated, with established dental care companies, pharmaceutical manufacturers, and specialized anesthesia technology providers competing across local anesthetics, sedation solutions, and advanced anesthesia delivery systems. Competition is mainly determined by clinical effectiveness, patient comfort, safety, product availability, delivery precision, healthcare-provider relationships, and distribution coverage. Dentsply Sirona, Septodont, Milestone Scientific, 3M, and Centrix are key players with strong positions across important categories of dental anesthesia and pain-management solutions.
The competitive environment is increasingly influenced by computer-controlled local anesthesia delivery, targeted anesthesia systems, advanced anesthetic formulations, buffered and needle-free solutions, and patient-centric sedation technologies. Companies are focusing on improving injection comfort, anesthesia precision, onset time, treatment predictability, and patient experience while expanding technology-enabled dental anesthesia options. Strategic partnerships, product launches, regulatory clearances, clinical evidence, and distribution agreements are expected to remain important strategies for strengthening market presence in the U.S.
U.S. Dental Anesthesia Market Companies:
Acteon Group
Aspen Holdings
Centrix, Inc.
Cetylite Industries, Inc.
ConvaTec Group
Dentalhitec
Dentsply Sirona Inc.
Fresenius Kabi USA
Henry Schein, Inc.
Hikma Pharmaceuticals PLC
Laboratorios Inibsa S.A.
Laboratorios Normon, S.A.
Milestone Scientific, Inc.
Pierrel S.p.A.
Primex Pharmaceuticals AG
Septodont Inc.
3M Company
Ultradent Products Inc.
Zeyco
Market Segmentation
This study provides revenue growth and emerging trends across global, regional, and country levels from 2021 to 2035, segmenting the U.S. dental anesthesia market by-
Product Type (Revenue in USD Million, 2021 - 2035)
Local
Injectable
Lidocaine 2% with Epinephrine
Mepivacaine 2% with Epinephrine
Mepivacaine 3% (Plain / Without Epinephrine)
Articaine 4% with Epinephrine
Bupivacaine 0.5% with Epinephrine
Others (Prilocaine 4% with epinephrine, etc.)
Topical
Benzocaine Gels
Subgingival Gels (Oraqix)
Sedation
General
Application (Revenue in USD Million, 2021 - 2035)
Restorative Dentistry
Endodontics
Surgical
Periodontics
Orthodontic
End-use (Revenue in USD Million, 2021 – 2035)
Dental Clinics
Hospitals
Ambulatory Surgery Centers (ASCs)
Academic & Research Institutes
Table of Content
1. Methodology and Scope
1.1. Scope of the Study
1.1.1. Market Segmentation
1.1.2. Market Definition
1.1.3. Inclusions and Exclusions of the Study
1.2. Research Design
1.2.1. Base Year, Historical Data, and Forecast Period
1.2.2. Data Collection Methods
1.2.2.1. Secondary Sources
1.2.2.2. Primary Sources
1.2.3. Research Methodology
1.2.3.1. Base Year Calculation/ Parent Market Analysis, Company/ Brand Share Analysis, 2025 (Top-down Approach)
1.2.3.2. Volume-Price Approach (Bottom-up Approach)
1.2.3.3. Data Triangulation
1.2.4. Forecasting Model
1.3. Research Assumptions
1.4. Validation and Data Quality Control
1.5. List of Primary Sources
1.6. List of Secondary Sources
2. Executive Summary
2.1. Market Overview
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
3. Industry Outlook
3.1. Industry Ecosystem Analysis
3.2. Parent/ Ancillary Market Analysis
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Restraints/ Challenges
3.3.3. Opportunities
3.4. Value Chain Analysis
3.5. Technology Roadmap
3.6. Porters Analysis
3.7. PESTLE Analysis
4. Market Estimates and Forecasts, By Product Type, 2021 - 2035 (Market Size in USD Mn)
4.1. Local
4.1.1. Injectable
4.1.1.1. Lidocaine 2% with Epinephrine
4.1.1.2. Mepivacaine 2% with Epinephrine
4.1.1.3. Mepivacaine 3% (Plain / Without Epinephrine)
4.1.1.4. Articaine 4% with Epinephrine
4.1.1.5. Bupivacaine 0.5% with Epinephrine
4.1.1.6. Others (Prilocaine 4% with epinephrine, etc.)
4.1.2. Topical
4.1.2.1. Benzocaine Gels
4.1.2.2. Subgingival Gels (Oraqix)
4.2. Sedation
4.3. General
5. Market Estimates and Forecasts, By Application, 2021 – 2035 (USD Mn)
5.1. Restorative Dentistry
5.2. Endodontics
5.3. Surgical
5.4. Periodontics
5.5. Orthodontic
6. Market Estimates and Forecasts, By End-use, 2021 – 2035 (USD Mn)
6.1. Dental Clinics
6.2. Hospitals
6.3. Ambulatory Surgery Centers (ASCs)
6.4. Academic & Research Institutes
7. Market Estimates and Forecasts, By U.S., 2021 - 2035 (USD Mn)
7.1.1. U.S.
7.1.1.1. U.S. Dental Anesthesia Market Estimates and Forecasts to 2035 (USD Mn)
7.1.1.2. Market Dynamics
7.1.1.3. Competitive Landscape
7.1.1.4. Regulatory Framework
7.1.1.5. Reimbursement Scenario
8. Competitive Landscape
8.1. Company Market Share Analysis, 2025
8.2. Company Tier Structure
8.3. List of Major Suppliers, By Key Countries
8.4. Key Company Positioning Analysis
8.5. Company Profile
8.5.1. Acteon Group
8.5.2. Aspen Holdings
8.5.3. Centrix, Inc.
8.5.4. Cetylite Industries, Inc.
8.5.5. ConvaTec Group
8.5.6. Dentalhitec
8.5.7. Dentsply Sirona Inc.
8.5.8. Fresenius Kabi USA
8.5.9. Henry Schein, Inc.
8.5.10. Hikma Pharmaceuticals PLC
8.5.11. Laboratorios Inibsa S.A.
8.5.12. Laboratorios Normon, S.A.
8.5.13. Milestone Scientific, Inc.
8.5.14. Pierrel S.p.A.
8.5.15. Primex Pharmaceuticals AG
8.5.16. Septodont Inc.
8.5.17. 3M Company
8.5.18. Ultradent Products Inc.
8.5.19. Zeyco
9. Analyst Perspective
10. Related Reports
Revolution Insights Briefs
Stay informed with updates on related market reports and key industry topics.